ANTI‐OXIDANT EFFECTS OF ATORVASTATIN IN DEXAMETHASONE‐INDUCED HYPERTENSION IN THE RAT
Authors:
- 16 October 2006
- journal article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 33 (11) , 1029-1034
Abstract
SUMMARY: Dexamethasone (Dex)‐induced hypertension is characterized by endothelial dysfunction associated with nitric oxide (NO) deficiency and increased superoxide () production. Atorvastatin (Ato) possesses pleiotropic properties that have been reported to improve endothelial function through increased availability of NO and reduced production in various forms of hypertension. In the present study, we investigated whether 50 mg/kg per day, p.o., Ato could prevent endothelial NO synthase (eNOS) downregulation and the increase in in Sprague‐Dawley (SD) rats, thereby reducing blood pressure. Male SD rats (n = 30) were treated with Ato (50 mg/kg per day in drinking water) or tap water for 15 days. Dexamethasone (10 µg/kg per day, s.c.) or saline was started after 4 days in Ato‐treated and non‐treated rats and continued for 11–13 days. Systolic blood pressure (SBP) was measured on alternate days using the tail‐cuff method. Endothelial function was assessed by acetylcholine‐induced vasorelaxation and phenylephrine‐induced vasoconstriction in aortic segments. Vascular eNOS mRNA was assessed by semi‐quantitative reverse transcription–polymerase chain reaction. In rats treated with Dex alone, SBP was increased from 109 ± 2 to 133 ± 2 mmHg on Days 4 and Day 14, respectively (P < 0.001). In the Ato + Dex group, SBP was increased from 113 ± 2 to 119 ± 2 mmHg on Days 4 to 14, respectively (P < 0.001), but was significantly lower than SBP in the group treated with Dex alone (P < 0.05). Endothelial‐dependent relaxation and eNOS mRNA expression were greater in the Dex + Ato group than in the Dex only group (P < 0.05 and P < 0.0001, respectively). Aortic superoxide production was lower in the Dex + Ato group compared with the group treated with Dex alone (P < 0.0001). Treatment with Ato improved endothelial function, reduced superoxide production and reduced SBP in Dex‐treated SD rats.Keywords
This publication has 31 references indexed in Scilit:
- Apocynin but Not Allopurinol Prevents and Reverses Adrenocorticotropic Hormone-Induced Hypertension in the RatAmerican Journal of Hypertension, 2005
- Atorvastatin Prevents End-Organ Injury in Salt-Sensitive HypertensionHypertension, 2004
- The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the ratAmerican Journal of Hypertension, 2004
- HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen SpeciesHypertension, 2001
- Suppression of Endothelial Nitric Oxide Production After Withdrawal of Statin Treatment Is Mediated by Negative Feedback Regulation of Rho GTPase Gene TranscriptionCirculation, 2000
- Two-Week Administration of Tempol Attenuates Both Hypertension and Renal Excretion of 8-Iso Prostaglandin F 2αHypertension, 1999
- Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjectsClinical Pharmacology & Therapeutics, 1996
- Fertility and General Reproduction Studies in Rats with the HMG-CoA Reductase Inhibitor, AtorvastatinFundamental and Applied Toxicology, 1996
- Increased Vasoconstrictor Sensitivity to Glucocorticoids in Essential HypertensionHypertension, 1996
- Study of mechanisms of glucocorticoid hypertension in rats: endothelial related changes and their amelioration by dietary fish oilsBritish Journal of Pharmacology, 1992